These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8959953)

  • 21. 75% Complete Response and 15% Partial Response to Extracorporeal Photopheresis Combined With Other Therapies in Resistant Early Stage Cutaneous T-Cell Lymphoma.
    Seremet S; Abhyankar S; Herd TJ; Aires D
    J Drugs Dermatol; 2016 Oct; 15(10):1212-1216. PubMed ID: 27741338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful implementation of a rural extracorporeal photopheresis program for the treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease in a rural hospital.
    Weber LL; Dunbar NM; Meehan KR; Szczepiorkowski ZM; Lansigan F
    J Clin Apher; 2015 Dec; 30(6):359-63. PubMed ID: 25691106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Photopheresis therapy for cutaneous T-cell lymphoma.
    Duvic M; Hester JP; Lemak NA
    J Am Acad Dermatol; 1996 Oct; 35(4):573-9. PubMed ID: 8859287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory/relapsed cutaneous T-cell lymphoma.
    Aviles A; Neri N; Fernandez-Diez J; Silva L; Nambo MJ
    Hematology; 2015 Oct; 20(9):538-42. PubMed ID: 25592781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence-based practice of photopheresis 1987-2001: a report of a workshop of the British Photodermatology Group and the U.K. Skin Lymphoma Group.
    McKenna KE; Whittaker S; Rhodes LE; Taylor P; Lloyd J; Ibbotson S; Russell-Jones R; ;
    Br J Dermatol; 2006 Jan; 154(1):7-20. PubMed ID: 16403088
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of stage II cutaneous T-cell lymphoma with interferon alfa-2a and extracorporeal photochemotherapy: a prospective controlled trial.
    Wollina U; Looks A; Meyer J; Knopf B; Koch HJ; Liebold K; Hipler UC
    J Am Acad Dermatol; 2001 Feb; 44(2):253-60. PubMed ID: 11174383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extracorporeal photochemotherapy in patients with cutaneous T-cell lymphoma: is clinical response predictable?
    Rao V; Ryggen K; Aarhaug M; Dai HY; Jørstad S; Moen T
    J Eur Acad Dermatol Venereol; 2006 Oct; 20(9):1100-7. PubMed ID: 16987266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic experiences with extracorporeal photopheresis. Technical procedure, follow-up and clinical outcome in 31 skin diseases].
    Owsianowski M; Garbe C; Ramaker J; Orfanos CE; Gollnick H
    Hautarzt; 1996 Feb; 47(2):114-23. PubMed ID: 8868455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the efficacy of the combination of oral bexarotene and methotrexate for the treatment of early stage treatment-refractory cutaneous T-cell lymphoma.
    Kannangara AP; Levitan D; Fleischer AB
    J Dermatolog Treat; 2009; 20(3):169-76. PubMed ID: 19016373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of advanced mycosis fungoides/Sézary syndrome with fludarabine and potential adjunctive benefit to subsequent extracorporeal photochemotherapy.
    Quaglino P; Fierro MT; Rossotto GL; Savoia P; Bernengo MG
    Br J Dermatol; 2004 Feb; 150(2):327-36. PubMed ID: 14996105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Photopheresis for the treatment of cutaneous T-cell lymphoma.
    Lim HW; Edelson RL
    Hematol Oncol Clin North Am; 1995 Oct; 9(5):1117-26. PubMed ID: 8522488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extracorporeal photopheresis: what is it and when should it be used?
    Scarisbrick J
    Clin Exp Dermatol; 2009 Oct; 34(7):757-60. PubMed ID: 19663836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term follow-up of patients with early-stage cutaneous T-cell lymphoma who achieved complete remission with psoralen plus UV-A monotherapy.
    Querfeld C; Rosen ST; Kuzel TM; Kirby KA; Roenigk HH; Prinz BM; Guitart J
    Arch Dermatol; 2005 Mar; 141(3):305-11. PubMed ID: 15781671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. U.K. consensus statement on the use of extracorporeal photopheresis for treatment of cutaneous T-cell lymphoma and chronic graft-versus-host disease.
    Scarisbrick JJ; Taylor P; Holtick U; Makar Y; Douglas K; Berlin G; Juvonen E; Marshall S;
    Br J Dermatol; 2008 Apr; 158(4):659-78. PubMed ID: 18241274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Photopheresis in the treatment of cutaneous T-cell lymphoma: current status.
    Zic JA
    Curr Opin Oncol; 2012 Jan; 24 Suppl 1():S1-10. PubMed ID: 22157241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in patients with leukaemic cutaneous T-cell lymphoma.
    Tsai YC; Schlaepfer T; Ignatova D; Chang YT; Valaperti A; Amarov B; Blanchard G; Pehr K; Vonow-Eisenring M; Urosevic-Maiwald M; Hoetzenecker W; Pascolo S; Iselin C; Fassnacht C; Dimitriou F; Bobrowicz M; Guenova E
    Br J Dermatol; 2023 Oct; 189(5):603-611. PubMed ID: 37409661
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experience with total skin electron beam therapy in combination with extracorporeal photopheresis in the management of patients with erythrodermic (T4) mycosis fungoides.
    Wilson LD; Jones GW; Kim D; Rosenthal D; Christensen IR; Edelson RL; Heald PW; Kacinski BM
    J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):54-60. PubMed ID: 10863224
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extracorporeal photochemotherapy restores Th1/Th2 imbalance in patients with early stage cutaneous T-cell lymphoma.
    Di Renzo M; Rubegni P; De Aloe G; Paulesu L; Pasqui AL; Andreassi L; Auteri A; Fimiani M
    Immunology; 1997 Sep; 92(1):99-103. PubMed ID: 9370930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Real-world use of extracorporeal photopheresis for patients with cutaneous T-cell lymphoma in the United States: 2010-2015.
    Ling YL; Huang X; Mitri G; Lovelace B; Pham A; Knobler R; Li X; Gao X
    J Dermatolog Treat; 2020 Feb; 31(1):91-98. PubMed ID: 30892982
    [No Abstract]   [Full Text] [Related]  

  • 40. A randomized cross-over study to compare PUVA and extracorporeal photopheresis in the treatment of plaque stage (T2) mycosis fungoides.
    Child FJ; Mitchell TJ; Whittaker SJ; Scarisbrick JJ; Seed PT; Russell-Jones R
    Clin Exp Dermatol; 2004 May; 29(3):231-6. PubMed ID: 15115499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.